Stay updated on GSK2857916 & Pembrolizumab in RRMM Clinical Trial

Sign up to get notified when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 and deleted Revision: v3.2.0 from the history.
    Difference
    0.1%
    Check dated 2025-11-25T10:16:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Notice about government funding and operating status is no longer displayed on the page.
    Difference
    0.5%
    Check dated 2025-11-18T06:42:15.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The new screenshot shows only minor visual adjustments to the Record History page. No changes to version entries or study data are visible.
    Difference
    0.1%
    Check dated 2025-11-03T16:53:14.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a government status notice and new version 3.2.0; removed the old version 3.1.0.
    Difference
    11%
    Check dated 2025-10-06T04:28:34.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T00:49:41.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.1 to v3.0.2, signaling a new release. The Back to Top element was removed, a minor UI/navigation change.
    Difference
    0.6%
    Check dated 2025-09-14T18:46:22.000Z thumbnail image

Stay in the know with updates to GSK2857916 & Pembrolizumab in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2857916 & Pembrolizumab in RRMM Clinical Trial page.